Batten Disease: Clinical Trials

1 trial for Batten Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Batten Disease: new trials by email Literature Review of Batten Disease trials Research Report on Batten Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene Therapy for Children With CLN3 Batten Disease
Low dose CLN-301, High dose CLN-301 - CLN3, Batten Disease
Phase 1 / Phase 2Active not recruitingNeela Therapeutics72018-11-132026-06-10

Narrower conditions

Neuronal Ceroid-Lipofuscinoses (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Lipid Metabolism Disorders (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Lipidoses (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Sponsors

Neela Therapeutics (1)

Countries

United States (1)

Top investigators

Kathrin C Meyer, PhD (1)

Results publications

PMID 37035740